biocon limited
Biocon, Advaxis To Develop Cancer Immunotherapy Against HPV
Biocon and Advaxis will co-develop and commercialize ADXS-HPV, a novel cancer immunotherapy for the treatment of HPV.
Abbott, Syngene To Open First Nutrition R&D Center In India
Abbott, in collaboration with Syngene, today announced plans to establish its first nutrition research and development center in India.
Biocon Inaugurates New Research Center In Bangalore, India
Indian pharmaceutical company, Biocon, announced on Thursday the inauguration of its new integrated R&D center in Bangalore.
Biocon Limited To Build US$161 Million R&D Facility in Bio-XCell, Malaysia
Indian biotech company Biocon Limited will build a biopharmaceutical manufacturing and R&D facility in Iskandar Malaysia, Johor.
Bangalore-Based Biocon Sells Majority Stake In AxiCorp
Bangalore-based Biocon Ltd. will divest a majority stake in its German unit AxiCorp GmbH for $58 million.








